Jaka jest cena za Aoxing Pharmaceutical Company, Inc. (AOXG)

Cena za Aoxing Pharmaceutical Company, Inc. (AOXG) wynosi $0.0022

Jaka jest kapitalizacja rynkowa dla Aoxing Pharmaceutical Company, Inc. (AOXG)

Kapitalizacja rynkowa dla Aoxing Pharmaceutical Company, Inc. (AOXG) wynosi $838.66K

Aoxing Pharmaceutical Company, Inc. (AOXG) Marża Operacyjna

Aoxing Pharmaceutical Company, Inc. is a specialized drug manufacturer primarily operating within the People's Republic of China. The company dedicates itself to the research, development, production, and distribution of pharmaceutical products, with a strong emphasis on narcotics, pain management solutions, and addiction treatments. Its current product portfolio includes Zhongtong'an, a capsule derived from herbal extracts used for relieving oral and dental discomfort; Yiqi Qiangshen Granule, an over-the-counter herbal preparation designed to invigorate qi, strengthen the body, and improve blood flow by clearing meridian blockages; and Tilidine hydrochloride. The latter is an oral synthetic narcotic analgesic tablet, available in 50mg or 100mg doses, prescribed for the alleviation of acute, moderate to severe pain, as well as chronic pain associated with cancer. Aoxing also boasts several promising products in its development pipeline. These include Oxycodone and Acetaminophen tablets and capsules, which have successfully completed clinical trials for both acute and chronic pain management. Another is Buprenorphine/Naloxone, a sublingual combination tablet that has finished Phase II clinical trials as a treatment for opioid dependence. Furthermore, a Tilidine/Naloxone compound capsule is currently undergoing Phase II clinical trials, targeting acute and chronic pain. Initially known as China Aoxing Pharmaceutical Company, Inc., the firm rebranded to Aoxing Pharmaceutical Company, Inc. in March 2010. Its corporate headquarters are situated in Shijiazhuang, China.

Rok	Marża operacyjna	Zmień
Za mało danych dla podanych dat.

Rok

Marża operacyjna

Zmień

Za mało danych dla podanych dat.

Firma	Marża operacyjna	Różnica w marży operacyjnej	Kraj
Royalty Pharma plc RPRX.US	62.34%	-	US
Swedish Orphan Biovitrum AB SOBI.ST	0.00%	-	SE
Ipsen S.A. IPN.PA	0.00%	-	FR
Sino Biopharmaceutical Limited 1177.HK	29.76%	-	HK
Recordati Industria Chimica e Farmaceutica S.p.A. REC.MI	0.00%	-	IT

Firma

Marża operacyjna

Różnica w marży operacyjnej

Kraj